Austin Sasha Lu 4

What Happened
Sasha Austin Lu, Vice President of Finance & Controller at Olema Pharmaceuticals (OLMA), received equity awards on February 2, 2026: 11,700 shares and 29,250 derivative securities, each reported with an acquisition price of $0 (total reported value $0). This was an award/grant (compensation) transaction, not an open‑market purchase or sale.

Key Details

• Transaction date: 2026-02-02; Filing date: 2026-02-17 (filed 15 days after the transaction; appears late vs. the usual 2-business-day Form 4 deadline).
• Awards: 11,700 shares (direct) and 29,250 derivative securities (reported as derivative awards), acquisition price $0.
• Shares owned after transaction: not specified in the provided filing excerpt.
• Footnote: 25% of the shares subject to the option vest on February 2, 2027, then 1/48 of the total each month thereafter, subject to continued service through each vesting date.
• Transaction code: A = Award/Grant.

Context
Derivative securities in Form 4s typically represent awards such as options or restricted stock units that convert to common shares only after vesting or exercise; the filing lists these as derivative awards and includes a multi-year vesting schedule. Because this was a compensation grant, it doesn’t reflect an open‑market buy or sell decision by the insider. Note the late filing may be a compliance issue and is worth monitoring for any company disclosures or corrective filings.